| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MMM | Common Stock | Options Exercise | $241,591 | +1,899 | +43% | $127.22 | 6,287 | 01 Nov 2024 | Direct | F1 |
| transaction | MMM | Common Stock | Tax liability | $110,173 | -866 | -14% | $127.22 | 5,421 | 01 Nov 2024 | Direct | |
| holding | MMM | Common Stock | 555 | 01 Nov 2024 | By 401k/paesop Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MMM | Restricted Stock Units | Options Exercise | $0 | -1,899 | -100% | $0.000000 | 0 | 01 Nov 2024 | Common Stock | 1,899 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | The shares originally reported were adjusted due to the spin-off of Solventum, the Company's healthcare business group, on April 1, 2024. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of 3M common stock. |
| F3 | The restricted stock units vest in three years from the grant date. |